54,034 research outputs found
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
Full text linkOral capecitabine (Xeloda<sup>®</sup>) is an effective drug with favourable safety in adjuvant and metastatic colorectal cancer. Oxaliplatin-based therapy is becoming standard for Dukes' C colon cancer in patients suitable for combination therapy, but is not yet approved by the UK National Institute for Health and Clinical Excellence (NICE) in the adjuvant setting. Adjuvant capecitabine is at least as effective as 5-fluorouracil/leucovorin (5-FU/LV), with significant superiority in relapse-free survival and a trend towards improved disease-free and overall survival. We assessed the cost-effectiveness of adjuvant capecitabine from payer (UK National Health Service (NHS)) and societal perspectives. We used clinical trial data and published sources to estimate incremental direct and societal costs and gains in quality-adjusted life months (QALMs). Acquisition costs were higher for capecitabine than 5-FU/LV, but higher 5-FU/LV administration costs resulted in 57% lower chemotherapy costs for capecitabine. Capecitabine vs 5-FU/LV-associated adverse events required fewer medications and hospitalisations (cost savings £3653). Societal costs, including patient travel/time costs, were reduced by >75% with capecitabine vs 5-FU/LV (cost savings £1318), with lifetime gain in QALMs of 9 months. Medical resource utilisation is significantly decreased with capecitabine vs 5-FU/LV, with cost savings to the NHS and society. Capecitabine is also projected to increase life expectancy vs 5-FU/LV. Cost savings and better outcomes make capecitabine a preferred adjuvant therapy for Dukes' C colon cancer. This pharmacoeconomic analysis strongly supports replacing 5-FU/LV with capecitabine in the adjuvant treatment of colon cancer in the UK
Characterization of Anodic Films on AZ31 Magnesium Alloys in Alkaline Solutions Containing Fluoride and Phosphate Anions
No full text
Differentiating personal facilitators of leisure participation: Socio-demographics, personality traits, and the need for sociability.
No full textShen C. Y. Fu, Challenging the Past. The Paintings of Chang Dai-chien
No full textThote Alain. Shen C. Y. Fu, Challenging the Past. The Paintings of Chang Dai-chien. In: Arts asiatiques, tome 48, 1993. pp. 171-172
“Mirror Image Effect” Space Charge Distribution in XLPE Power Cable under Opposite Stressing Voltage Polarity
No full textThe paper presents space charge distributions under opposite voltage polarities in full size cross-linked polyethylene power cables using the pulsed electro-acoustic technique. Under both positive and negative polarities, space charge distributions possess similar profiles but opposite polarities. A similar phenomenon had been reported previously in plaque samples and was termed the “mirror image effect”. By comparing the results between cables treated by degassing under different conditions, the paper concludes that the “mirror image” charge distribution is mainly attributed to a bulk effect within the volume of the insulation, whilst electron transfer by tunneling through an electrode/insulator interface contributes to the generation of homo “mirror image” close to the electrodes
Branching fraction and CP asymmetry of the decays B+→K0Sπ+ and B+→K0SK+
Full text linkAn analysis of B+ → K0
Sπ+ and B+ → K0
S K+ decays is performed with the LHCb experiment. The pp
collision data used correspond to integrated luminosities of 1 fb−1 and 2 fb−1 collected at centre-ofmass
energies of
√
s = 7 TeV and
√
s = 8 TeV, respectively. The ratio of branching fractions and the
direct CP asymmetries are measured to be B(B+ → K0
S K+
)/B(B+ → K0
Sπ+
) = 0.064 ± 0.009 (stat.) ±
0.004 (syst.), ACP(B+ → K0
Sπ+
) = −0.022 ± 0.025 (stat.) ± 0.010 (syst.) and ACP(B+ → K0
S K+
) =
−0.21 ± 0.14 (stat.) ± 0.01 (syst.). The data sample taken at
√
s = 7 TeV is used to search for
B+
c
→ K0
S K+ decays and results in the upper limit ( fc · B(B+
c
→ K0
S K+
))/( fu · B(B+ → K0
Sπ+
)) <
5.8 × 10−2 at 90% confidence level, where fc and fu denote the hadronisation fractions of a ¯b
quark
into a B+
c or a B+ meson, respectively
- …
